Emedonline: Telemedicine Medication Management System

Emedonline：远程医疗用药管理系统

• 批准号: 6644405
• 负责人: Barbara Ann Rapchak
• 金额: $ 10万
• 依托单位: LEAP OF FAITH TECHNOLOGIES, INC.
• 依托单位国家: 美国
• 财政年份: 2003
• 资助国家: 美国
• 起止时间: 2003-08-01 至 2004-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6644405
• 关键词: chemotherapy; clinical research; drug administration rate /duration; human old age (65+); human subject; hypertension; self medication; technology /technique development; telemedicine; therapy compliance

DESCRIPTION (provided by investigator): Medication non-compliance is estimated to cost the US healthcare system an estimated $76.6 billion a year. Approximately 10% of hospital admissions are related to medication issues, costing up to $50 billion annually. Understanding the causes of noncompliance and identifying methods to help patients follow their regimens may improve health outcomes and reduce related costs. We propose to determine whether a medication management system improves compliance among elderly patients being treated for hypertension. The medication management system, called Emedonline, uses standard cellular phone technology to call patients at programmed intervals, gives voice, text, and graphic instructions for taking prescribed medications, and dispenses the medications. It focuses specifically on modifying social interaction factors and providing a tool to enhance the administration process. We have identified three key objectives toward achieving Phase I and Phase II goals: 1. Develop Emedonline to facilitate prescribing medication regimens for healthcare providers, and facilitate medication compliance for patients. 2. Assess the acceptability of the service among healthcare providers, pharmacists, and patients. 3. Evaluate effects on medication compliance, perceived social support, and feelings of control over health destiny. During Phase I, we will examine requirements through focus groups with a sample of healthcare providers, pharmacists, and patients; develop a prototype of the Emedonline system; conduct a concept test with the sample; and create detailed specifications for Phase II development.

描述（由研究者提供）：据估计，药物不合规每年会给美国医疗保健系统造成 766 亿美元的损失。 大约 10% 的住院病例与药物问题有关，每年花费高达 500 亿美元。 了解不依从的原因并确定帮助患者遵循其治疗方案的方法可以改善健康结果并降低相关成本。 我们建议确定药物管理系统是否可以提高接受高血压治疗的老年患者的依从性。名为 Emedonline 的药物管理系统使用标准移动电话技术，按照设定的时间间隔呼叫患者，提供语音、文本和图形说明，以指导患者服用处方药物，并分发药物。它特别侧重于改变社会互动因素并提供增强管理流程的工具。 我们确定了实现第一阶段和第二阶段目标的三个关键目标： 1. 开发 Emedonline 以方便医疗保健提供者制定药物治疗方案，并促进患者的用药依从性。 2. 评估医疗保健提供者、药剂师和患者对服务的接受程度。 3. 评估对药物依从性、感知社会支持以及对健康命运的控制感的影响。 在第一阶段，我们将通过焦点小组以医疗保健提供者、药剂师和患者为样本来检查要求；开发 Emedonline 系统原型；对样品进行概念测试；并为第二阶段开发制定详细规范。